Margetuximab

Tax included
Margetuximab (MGAH22) is a chimeric anti-HER2 monoclonal antibody optimized Fc domain, with an EC50 value of 39.33 ng/mL. Margetuximab can be used for researching metastatic HER2-positive breast cancer.
MedChemExpress 
HY-P99030

Data sheet

Size
Multiple sizes
Reactivity
EGFR
Application
Cancer-Kinase/protease
CAS
1350624-75-7